Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Mar;27(3):438-42.
doi: 10.1038/eye.2012.259. Epub 2013 Jan 4.

Photodynamic therapy for retinal capillary hemangioma

Affiliations
Case Reports

Photodynamic therapy for retinal capillary hemangioma

V P Papastefanou et al. Eye (Lond). 2013 Mar.

Abstract

Purpose: To describe the results of photodynamic therapy (PDT) for juxtapapillary and peripheral retinal capillary hemangioma (RCH).

Patients and methods: Interventional case series of four eyes (four patients) with juxtapapillary RCH and one eye (one patient) with peripheral RCH. Two eyes with juxtapapillary RCH had received two sessions of full-fluence, double-duration PDT; whereas other two eyes had received single session of half-fluence, single-duration PDT. The peripheral RCH was treated with a single session of full-fluence, single-duration PDT.

Results: Two patients had von Hippel-Lindau disease. Follow-up duration ranged from 4 months to 1 year. Pre-PDT visual acuity (VA) ranged from 20/200 to HM (juxtapapillary RCH) and 20/100 (peripheral RCH). Among the eyes with juxtapapillary RCH, tumor regression with partial resolution of macular edema was noted in two eyes (one eye each with half-fluence and full-fluence PDT), whereas two eyes had no change in tumor size with persistent macular edema. VA remained stable in three eyes and declined in one eye. In an eye with peripheral RCH, regression of tumor and macular edema with VA improvement was noted. Post-PDT complications included epiretinal membrane (one eye) and transient exudative retinal detachment (one eye).

Conclusion: PDT can be effective in reducing macular edema associated with RCH but this does not always correspond with an improvement in VA especially for juxtapapillary tumors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Color fundus photographs (CF) and spectral domain optical coherence tomography (SDOCT) foveal B scans of the right eye of a 32-year-old male (patient 2; a–d) and of a 52-year-old female patient (patient 4). (a) CF photograph of the posterior pole shows a juxtapapillary capillary hemangioma (before PDT) with associated exudative RD. (b) CF photograph shows no change in the capillary hemangioma (21 months after PDT). (c) SDOCT foveal B scan shows macular RD (before PDT). (d) SDOCT foveal B scan shows no significant change (21 months after PDT). (e) CF photograph of the posterior pole shows a juxtapapillary capillary hemangioma overlying the optic nerve (before PDT). (f) CF photograph of the posterior pole shows significant reduction and fibrosis of the capillary hemangioma (26 months after PDT). (g) SDOCT foveal B scan shows macular RD (before PDT). (h) SDOCT foveal B scan shows partial resolution of macular edema with an epiretinal membrane (26 months after PDT).
Figure 2
Figure 2
Color fundus (CF) photographs and spectral domain optical coherence tomography (SDOCT) foveal B scans of the right eye of a 32-year-old female (patient 5) (a–e). (a) CF photograph of the retinal periphery shows a RCH (before PDT). (b) CF photograph of the retinal periphery shows an area of exudative RD and an area of subretinal hemorrhage (1 week after PDT). (c) CF photograph of the retinal periphery shows a regressed RCH (9 months after PDT). (d) SDOCT foveal B scan suggestive of a serous macular detachment (1 week after PDT). (e) SDOCT foveal B scan shows resolved serous macular detachment (2 weeks after PDT). (f) CF photograph of the macula shows regressed exudates with RPE alteration in the fovea. (g) CF photograph of the retinal periphery shows a regressed RCH (9 months after PDT).

References

    1. Singh AD, Nouri M, Shields CL, Shields JA, Perez N. Treatment of retinal capillary haemangioma. Ophthalmology. 2002;109:1799–1806. - PubMed
    1. Schmidt-Erfurth UM, Kusserow C, Barbazetto IA, Laqua H. Benefits and complications of photodynamic therapy of papillary capillary haemangiomas. Ophthalmology. 2002;109 (7:1256–1266. - PubMed
    1. Atebara NH. Retinal capillary haemangioma treated with verteporfin photodynamic therapy. Am J Ophthalmol. 2002;134:788–790. - PubMed
    1. Aaberg JrTM, Aaberg SrTM, Martin DF, Gilman JP, Myles R. Three cases of large retinal capillary haemangiomas treated with verteporfin and photodynamic therapy. Arch Ophthalmol. 2005;123 (3:328–332. - PubMed
    1. Golshevsky JR, O'Day J. Photodynamic therapy in the management of juxtapapillary capillary haemangiomas. Clin Experiment Ophthalmol. 2005;33 (5:509–512. - PubMed

Publication types

LinkOut - more resources